GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
5UJT | 5UJT | Crystal structure of human HLA-DQ8 in complex with insulin mimotope binding in register 3 | |
5UJZ | 5UJZ | CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 1 | |
5UK0 | 5UK0 | CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 2 | |
5UK1 | 5UK1 | CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 3 | |
5UK2 | 5UK2 | CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 4 | |
5UKR | 5UKR | Structure of unliganded anti-gp120 CD4bs antibody DH522.2 Fab in complex with a gp120 core | |
5UM8 | 5UM8 | Crystal structure of HIV-1 envelope trimer 16055 NFL TD CC (T569G) in complex with Fabs 35022 and PGT124 | |
5UMN | 5UMN | Crystal structure of C05 VPGSGW mutant bound to H3 influenza hemagglutinin, HA1 subunit | |
5UN8 | 5UN8 | Crystal Structure of human O-GlcNAcase in complex with glycopeptide p53 | |
5UOW | 5UOW | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
5UP2 | 5UP2 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, Ro 25-6981, MK-801 and a GluN2B-specific Fab, at pH 6.5 | |
5UQY | 5UQY | Crystal structure of Marburg virus GP in complex with the human survivor antibody MR78 | |
5UTF | 5UTF | Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M in Complex with Human Antibodies PGT122 and 35O22 at 4.3 A | |
5UTY | 5UTY | Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, N300M, N302M, T320L in Complex with Human Antibodies PGT122 and 35O22 at 4.1 Angstrom | |
5UUY | 5UUY | Crystal structure of Dioclea lasiocarpa lectin (DLL) complexed with X-MAN | |
5V2A | 5V2A | Crystal structure of Fab H7.167 in complex with influenza virus hemagglutinin from A/Shanghai/02/2013 (H7N9) | |
5V4M | 5V4M | Structure of HLA-DR15 with bound alpha3(135-145) peptide | |
5V4M | 5V4M | Structure of HLA-DR15 with bound alpha3(135-145) peptide | |
5V4N | 5V4N | Structure of HLA-DR1 with bound alpha3(135-145) peptide | |
5V4N | 5V4N | Structure of HLA-DR1 with bound alpha3(135-145) peptide | |
5V7J | 5V7J | Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22. | |
5V8L | 5V8L | BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 | |
5V8M | 5V8M | BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117 | |
5VAK | 5VAK | Crystal Structure of Beta-Klotho, Domain 1 | |
5VAN | 5VAN | Crystal Structure of Beta-Klotho | |
5VAQ | 5VAQ | Crystal Structure of Beta-Klotho in Complex with FGF21CT | |
5VCJ | 5VCJ | Structure of alpha-galactosylphytosphingosine bound by CD1d and in complex with the Va14Vb8.2 TCR | |
5VCN | 5VCN | THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8 | |
5VCO | 5VCO | THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9 | |
5VEB | 5VEB | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
5VEB | 5VEB | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
5VF2 | 5VF2 | scFv 2D10 re-refined as a complex with trehalose replacing the original alpha-1,6-mannobiose | |
5VGJ | 5VGJ | Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated from Donor N90, bound to a scaffolded WITO V1V2 domain | |
5VH5 | 5VH5 | Crystal Structure of Fc fragment of anti-TNFa antibody infliximab | |
5VIE | 5VIE | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase | |
5VIF | 5VIF | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase | |
5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
5VK2 | 5VK2 | Structural basis for antibody-mediated neutralization of Lassa virus | |
5VL3 | 5VL3 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
5VL3 | 5VL3 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
5VLI | 5VLI | Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934) | |
5VN3 | 5VN3 | Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b | 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
5VN8 | 5VN8 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | |
5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | |
5VOC | 5VOC | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | |
5VOC | 5VOC | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | |
5VOD | 5VOD | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
5VOD | 5VOD | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024